Halloran Speaker Series: Navigating the Complexities of Expedited Product Approval Pathways

2:00 PM - 3:00 PM

Global health authorities have long recognized the need to facilitate development and minimize delays in patient access for novel treatments intended for serious and life-threatening disease. Over the past decade, FDA, EMA and PMDA have launched ...